Gregory A Hickel, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 610 N Hirsch Ave, Ellinwood, KS 67526 Phone: 620-564-3069 Fax: 620-564-3069 |
News Archive
We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect prostate cancer using an electronic nose. In a proof of principle study, the eNose successfully discriminated between prostate cancer and benign prostatic hyperplasia (BPH) by "sniffing" urine headspace (the space directly above the urine sample). Results using the eNose are comparable to testing prostate specific antigen (PSA), reports the Journal of Urology.
"Violence against women is a global epidemic, threatening the lives and safety of women and girls around the world," Sen. Benjamin Cardin (D-Md.), chairman of the U.S. Helsinki Commission, writes in a Baltimore Sun opinion piece in which he asserts his support of the International Violence Against Women Act. In the piece, Cardin describes how violence against women increases risks of health problems - such as dying in pregnancy and contracting HIV - and poverty (2/19).
Despite intense research, there's been much confusion regarding the exact role of a protein in a critical cancer-linked pathway. On one hand, the protein is described as a cell proliferation inhibitor, on the other, a cell proliferation activator, a duality that has caused a great deal of scientific head scratching.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology Meeting on Sunday, June 2.
› Verified 8 days ago